Hideo Ôta

1.6k total citations
53 papers, 1.3k citations indexed

About

Hideo Ôta is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hideo Ôta has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Hepatology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hideo Ôta's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastrointestinal Tumor Research and Treatment (6 papers). Hideo Ôta is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastrointestinal Tumor Research and Treatment (6 papers). Hideo Ôta collaborates with scholars based in Japan. Hideo Ôta's co-authors include Morito Monden, Keizo Dono, Hiroaki Nagano, Koji Umeshita, Atsushi Miyamoto, Masato Sakon, Hiroshi Wada, Masato Nakamura, Shigeru Marubashi and Shoji Nakamori and has published in prestigious journals such as Cancer, Clinical Cancer Research and Journal of Hepatology.

In The Last Decade

Hideo Ôta

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideo Ôta Japan 16 625 399 373 325 313 53 1.3k
Shinji Osada Japan 21 306 0.5× 477 1.2× 332 0.9× 164 0.5× 596 1.9× 113 1.5k
Nigel C. Bird United Kingdom 17 266 0.4× 260 0.7× 373 1.0× 257 0.8× 467 1.5× 28 1.1k
Koji Miyahara Japan 17 276 0.4× 171 0.4× 275 0.7× 335 1.0× 309 1.0× 45 906
Chengjun Sui China 23 362 0.6× 449 1.1× 679 1.8× 625 1.9× 495 1.6× 58 1.5k
Enxiao Li China 17 302 0.5× 232 0.6× 340 0.9× 213 0.7× 671 2.1× 45 1.2k
Su Cheol Park South Korea 19 755 1.2× 288 0.7× 224 0.6× 217 0.7× 300 1.0× 30 1.2k
Xiang Xiao China 14 239 0.4× 185 0.5× 365 1.0× 245 0.8× 410 1.3× 29 1.1k
Hirofumi Kubota Japan 25 145 0.2× 702 1.8× 475 1.3× 250 0.8× 417 1.3× 42 1.6k
Ugochukwu C. Nzeako United States 14 288 0.5× 195 0.5× 144 0.4× 108 0.3× 189 0.6× 19 1.1k
Chengyong Qin China 19 214 0.3× 171 0.4× 313 0.8× 187 0.6× 217 0.7× 46 862

Countries citing papers authored by Hideo Ôta

Since Specialization
Citations

This map shows the geographic impact of Hideo Ôta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideo Ôta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideo Ôta more than expected).

Fields of papers citing papers by Hideo Ôta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideo Ôta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideo Ôta. The network helps show where Hideo Ôta may publish in the future.

Co-authorship network of co-authors of Hideo Ôta

This figure shows the co-authorship network connecting the top 25 collaborators of Hideo Ôta. A scholar is included among the top collaborators of Hideo Ôta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideo Ôta. Hideo Ôta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ôta, Hideo, et al.. (2024). [Edwardsiella tarda Bacteremia in the Setting of Recurrence at the Hepatic Hilum after Surgery for Lower Bile Duct Cancer-A Case Report].. PubMed. 51(13). 1627–1629.
2.
Miyazaki, Hidetaka, Shigekazu Yokoyama, Kazuma Ito, et al.. (2020). A Case of Mature Teratoma in the Hepatoduodenal Ligament. Gan to kagaku ryōhō. 47(13). 2239–2241. 1 indexed citations
3.
Tokuyama, Shinji, Mutsumi Fukunaga, Kazuyuki Okada, et al.. (2018). [A Case of Hyperammonemia Induced by Chemotherapy with 5-Fluorouracil for Metastatic Colon Cancer].. PubMed. 45(4). 743–745. 1 indexed citations
4.
Ôta, Hideo, et al.. (2017). Endovascular Treatment of Hepatic Artery Pseudoaneurysm After Pancreaticoduodenectomy: Risk Factors Associated With Mortality and Complications. Journal of Vascular Surgery. 65(3). 923–924. 3 indexed citations
5.
Yoshioka, Shinichi, Masahiko Kubo, Kazuyuki Okada, et al.. (2015). [A Case of Liposarcoma Occurring in the Retroperitoneum Treated by Laparoscopic Excision].. PubMed. 42(12). 1941–3. 1 indexed citations
6.
Murata, Kohei, Hirotsugu Nagase, Kazuyuki Okada, et al.. (2009). [A case of liver metastasis treated by cetuximab monotherapy with partial response].. PubMed. 36(12). 2155–7.
7.
Yasumoto, Taku, Takuma Yamamoto, Yoshito Tomimaru, et al.. (2007). [Transcatheter arterial embolization for the continuous bleeding from duodenal carcinoma--a case report].. PubMed. 34(12). 2141–3. 1 indexed citations
8.
Yang, Yubo, Hiroaki Nagano, Hideo Ôta, et al.. (2007). Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery. 141(2). 196–202. 179 indexed citations
9.
Yamamoto, Tameyoshi, Hiroaki Nagano, Yasuharu Imai, et al.. (2007). Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy. International Journal of Clinical Oncology. 12(2). 150–154. 4 indexed citations
10.
Nagano, Hiroaki, Masato Sakon, Hidetoshi Eguchi, et al.. (2007). Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.. PubMed. 54(73). 172–9. 44 indexed citations
11.
Nakamura, Masato, Hiroaki Nagano, Masato Sakon, et al.. (2006). Role of the Fas/FasL pathway in combination therapy with interferon-α and fluorouracil against hepatocellular carcinoma in vitro. Journal of Hepatology. 46(1). 77–88. 57 indexed citations
12.
Nagano, Hiroaki, Hirofumi Yamamoto, Hiroshi Wada, et al.. (2006). Angiogenesis in cholangiocellular carcinoma: Expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. Oncology Reports. 15(3). 525–32. 75 indexed citations
13.
14.
15.
Ôta, Hideo, Yuichiro� Doki, Mitsugu Sekimoto, et al.. (2006). Expression of type I interferon receptor as a predictor of clinical response to interferon-α therapy of gastrointestinal cancers. Oncology Reports. 16(2). 249–55. 13 indexed citations
16.
Wada, Hiroshi, Hiroaki Nagano, Hirofumi Yamamoto, et al.. (2006). Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin‐2 and hypoxia‐induced factor‐1a. Liver International. 26(4). 414–423. 114 indexed citations
17.
18.
Morimoto, Osakuni, Hiroaki Nagano, Masato Sakon, et al.. (2003). Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. Journal of Hepatology. 39(2). 215–221. 95 indexed citations
19.
Gotoh, Mitsukazu, Keizo Dono, Michi Nishihara, et al.. (1998). Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts. Diabetologia. 41(3). 315–321. 45 indexed citations
20.
Takekoshi, T, Yoshihiro Baba, Hideo Ôta, et al.. (1994). Endoscopic Resection of Early Gastric Carcinoma: Results of a Retrospective Analysis of 308 Cases. Endoscopy. 26(4). 352–358. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinji Osada Breakdown of academic impact, for papers by Nigel C. Bird Breakdown of academic impact, for papers by Koji Miyahara Breakdown of academic impact, for papers by Chengjun Sui Breakdown of academic impact, for papers by Enxiao Li Breakdown of academic impact, for papers by Su Cheol Park Breakdown of academic impact, for papers by Xiang Xiao Breakdown of academic impact, for papers by Hirofumi Kubota Breakdown of academic impact, for papers by Ugochukwu C. Nzeako Breakdown of academic impact, for papers by Chengyong Qin
Rankless by CCL
2026